Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Nov 15:33:100485.
doi: 10.1016/j.ensci.2023.100485. eCollection 2023 Dec.

Neurological complications after COVID-19: A narrative review

Affiliations
Review

Neurological complications after COVID-19: A narrative review

Ghazale Molaverdi et al. eNeurologicalSci. .

Abstract

COVID-19 is primarily classified as a respiratory disorder; however, various neurological symptoms have been reported in COVID-19 patients. Neurological manifestations may be the initial signs of COVID-19 and can develop in patients of different age groups and with or without underlying disease. COVID-19 causes a broad range of complications in the central nervous system. These include headaches, altered mental status, dizziness, seizures, cerebrovascular events, encephalitis, and other encephalopathies. Moreover, a broad spectrum of peripheral nervous system symptoms such as olfactory and gustatory dysfunctions, neuropathy, visual impairments, neuralgia, cranial nerves palsy, and muscle involvement could manifest as symptoms. Despite various efforts, the exact pathogenesis of the COVID-19 neurological complications has not been clarified yet. Moreover, the reason for the development of neurological manifestation in only some COVID-19 patients has not been determined. This review focuses on the different neurological symptoms associated with COVID-19 and the possible pathological mechanisms hoping to provide new insights for diagnosis, therapies, or other forms of intervention.

Keywords: COVID-19; Central nervous system; Peripheral nervous system; SARS-CoV-2.

PubMed Disclaimer

Conflict of interest statement

All authors declare that they have no conflicts of interest and have never published the manuscript.

Similar articles

Cited by

References

    1. Letafati A., Salahi Ardekani O., Karami H., Soleimani M. Ebola virus disease: a narrative review. Microb. Pathog. 2023;181 - PubMed
    1. Letafati A., Sakhavarz T. Monkeypox virus: A review. Microb. Pathog. 2023;176 - PMC - PubMed
    1. WHO. 2023.
    1. Vogel L. Making sense of monkeypox death rates. CMAJ : Canadian Med. Assoc. J. = J. l’Assoc. Med. Canadienne. 2022;194(31):E1097. - PMC - PubMed
    1. Abdel-Mannan O., Eyre M., Löbel U., Bamford A., Eltze C., Hameed B., Hemingway C., Hacohen Y. Neurologic and Radiographic Findings Associated with COVID-19 Infection in Children. JAMA Neurol. 2020:E1–E6. - PMC - PubMed

LinkOut - more resources